The BMP2K Knockout HEK293T Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human HEK293T cell line, designed to disrupt the BMP2K gene. This loss-of-function model provides a tool to investigate BMP2K, a BMP-2-inducible serine/threonine kinase involved in clathrin-mediated endocytosis and actin dynamics. The polyclonal format delivers a heterogeneous pool of edited cells, enabling bulk functional assays without the need for single-cell cloning.
The HEK293T host cell line is an epithelial derivative of human embryonic kidney cells, extensively utilized for recombinant protein expression, viral production, and signal transduction studies due to its high transfection efficiency. These cells stably express the SV40 large T antigen, which promotes episomal replication of plasmids containing the SV40 origin, leading to high transient expression levels. This background makes it an ideal platform for dissecting gene function in endocytic trafficking and intracellular signaling.
BMP2K encodes a kinase induced by BMP-2/BMP-4 signaling through BMPR1A/1B receptors and SMAD1/5/8 transcription factors. It phosphorylates key components of the clathrin-mediated endocytosis machinery, including the clathrin heavy chain (CLTC) and AP2 complex subunits, as well as the actin regulator cortactin (CTTN). These phosphorylation events modulate receptor internalization (e.g., EGFR) and actin cytoskeleton reorganization. BMP2K interacts with CLTC, AP2A2, CTTN, and SRC, and functions at the nexus of BMP, endocytic, and Wnt pathways, influencing osteoblast differentiation via RUNX2 and cancer cell migration.
In the HEK293T context, BMP2K knockout allows precise dissection of its endocytic and cytoskeletal roles without confounding tissue-specific variables. The cells?? high transfectability facilitates rescue experiments and reporter assays to validate target engagement. Since HEK293T endogenously expresses BMP receptor complexes, SMAD proteins, and endocytic adaptors, this model enables quantitative assessment of BMP2K-dependent effects on signal transduction kinetics and receptor trafficking, including EGFR internalization.
Key applications include studying BMP-induced osteoblast differentiation using ALP staining, analyzing clathrin-mediated endocytosis via transferrin uptake assays, and evaluating cell migration through scratch wound assays. Additional techniques such as co-immunoprecipitation, Western blot, immunofluorescence, and flow cytometry can map interactomes, monitor phosphorylation, and quantify surface receptor levels. This polyclonal knockout model is suited for drug target validation and inhibitor screening in bone biology and cancer research. For technical inquiries, please contact Ascent Research.
